3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) saw a large growth in short interest in April. As of April 30th, there was short interest totaling 395,582 shares, a growth of 646.4% from the April 15th total of 53,000 shares. Based on an average daily trading volume, of 236 shares, the short-interest ratio is presently 1,676.2 days.
3SBio Stock Performance
OTCMKTS TRSBF remained flat at $2.85 during trading on Wednesday. 3SBio has a 12-month low of $2.22 and a 12-month high of $4.74. The stock has a fifty day simple moving average of $2.78 and a two-hundred day simple moving average of $3.19.
3SBio Company Profile
3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.
The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.
See Also
- Five stocks we like better than 3SBio
- Dream Finders Homes’ Hostile Bid Creates a Dual Squeeze Play
- Why OpenAI’s IPO Plans Could Be a Massive Win for Microsoft
- A Real Biggie Deal: Wendy’s Serves Up a Juicy Buyout Arbitrage
- Ally Financial Is Back to Basics—And Investors Are Watching
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
